ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreMain Content
ACR Preparing Feedback For HHS About Clinical AI Adoption
Jan. 8, 2026
ACR® is developing comments in response to a U.S. Department of Health and Human Services (HHS) Request for Information (RFI) that seeks input on topics including clinical AI regulation, reimbursement, and research and development to advance AI used in patient care.
Specifically, HHS is interested in learning about how these areas of federal influence can be leveraged to encourage clinical AI adoption and use, foster public trust and confidence, improve policy clarity, and align federal incentives. The RFI features a series of broad discussions followed by targeted questions for stakeholders' consideration.
If you have questions or would like to provide input to be considered for ACR’s response to the RFI, contact Michael Peters, Senior Director, Government Affairs, Lindsay Robbins, Regulatory Policy Specialist, or Christina Berry, Team Lead, Economic Policy.
